z-logo
Premium
B‐type natriuretic peptide predicts stroke of presumable cardioembolic origin in addition to coronary artery calcification
Author(s) -
Kara K.,
Gronewold J.,
Neumann T.,
Mahabadi A. A.,
Weimar C.,
Lehmann N.,
Berger K.,
Kälsch H. I. M.,
Bauer M.,
BroeckerPreuss M.,
Möhlenkamp S.,
Moebus S.,
Jöckel K.H.,
Erbel R.,
Hermann D. M.
Publication year - 2014
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/ene.12411
Subject(s) - medicine , cardiology , atrial fibrillation , hazard ratio , stroke (engine) , heart failure , coronary artery disease , myocardial infarction , blood pressure , proportional hazards model , natriuretic peptide , population , confidence interval , mechanical engineering , environmental health , engineering
Background and purpose B‐type natriuretric peptide ( BNP ) is a marker of cardiac dysfunction that is released from myocytes in response to ventricular wall stress. Previous studies suggested that BNP predicts stroke events in addition to classical risk factors. It was suggested that the BNP ‐associated risk results from coronary atherosclerosis or atrial fibrillation. Methods Three thousand six hundred and seventy five subjects from the population‐based Heinz Nixdorf Recall study (45–75 years; 47.6% men) without previous stroke, coronary heart disease, myocardial infarcts, open cardiac valve surgery, pacemakers and defibrillators were followed up over 110.1 ± 23.1 months. Cox proportional hazards regressions were used to examine BNP as a stroke predictor in addition to vascular risk factors (age, gender, systolic blood pressure, low‐density lipoprotein, high‐density lipoprotein, diabetes, smoking), renal insufficiency, atrial fibrillation/known heart failure and coronary artery calcification. Results Eighty‐nine incident strokes occurred (80 ischaemic, 9 hemorrhagic). Subjects suffering stroke had significantly higher BNP values at baseline than the remaining subjects [26.3 (Q1; Q3 = 12.9; 51.0) vs. 17.4 (9.4; 31.4); P  <   0.001]. In a multivariable regression, log 10 BNP was an independent stroke predictor [hazard ratio 1.96, 95% confidence interval (CI) 1.13–3.41; P  =   0.017] in addition to age (1.24 per 5 years, CI 1.04–1.49; P  =   0.016), systolic blood pressure (1.25 per 10 mmHg, CI 1.14–1.38; P  <   0.001), smoking (2.05, CI 1.24–3.39; P  =   0.005), atrial fibrillation/heart failure (2.25, CI 1.05–4.83; P  =   0.037) and computed‐tomography‐based log 10 (coronary artery calcification + 1) (1.47, CI 1.15–1.88; P  =   0.002). Log 10 BNP predicted stroke in men but not women, both in subjects ≤65 and >65 years. In subsequent analyses, BNP discriminated the incidence of cardioembolic stroke ( P for trend = 0.001), but not stroke of macroangiopathic ( P  =   0.555), microangiopathic ( P  =   0.809) or unknown ( P  =   0.367) origin. Conclusions BNP predicts presumable cardioembolic stroke independent of coronary calcification.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom